CRISPR

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

407

Employees407

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

407

Employees407

CRSP Key Statistics

Market cap

4.39B

Market cap4.39B

Price-Earnings ratio

-17.96

Price-Earnings ratio-17.96

Dividend yield

—

Dividend yield—

Average volume

1.59M

Average volume1.59M

High today

$53.26

High today$53.26

Low today

$51.01

Low today$51.01

Open price

$51.40

Open price$51.40

Volume

570.37K

Volume570.37K

52 Week high

$91.10

52 Week high$91.10

52 Week low

$43.42

52 Week low$43.42

CRSP News

TipRanks 2d

Crispr Therapeutics reports Q3 EPS ($1.01), consensus ($1.42)

Reports Q3 revenue $602,000, consensus $6.81M. “We continue to make significant progress across our pipeline of in vivo and ex vivo CRISPR-based therapies,” sai...

Analyst ratings

52%

of 31 ratings

Buy

51.6%

Hold

38.7%

Sell

9.7%